A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

NCT02964910 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis E

Interventions

BIOLOGICAL: Recombinant Hepatitis E Vaccine (Escherichia Coli)

Sponsor

Xiamen Innovax Biotech Co., Ltd